Branden S Moriarity


Research output per year

If you made any changes in Pure these will be visible here soon.

Fingerprint The Fingerprint is created by mining the titles and abstracts of the person's research outputs and projects/funding awards to create an index of weighted terms from discipline-specific thesauri.

  • 16 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.


Research Output

A Genetically Engineered Primary Human Natural Killer Cell Platform for Cancer Immunotherapy

Pomeroy, E. J., Hunzeker, J. T., Kluesner, M. G., Lahr, W. S., Smeester, B. A., Crosby, M. R., Lonetree, C. L., Yamamoto, K., Bendzick, L., Miller, J. S., Geller, M. A., Walcheck, B., Felices, M., Webber, B. R., Starr, T. K. & Moriarity, B. S., Jan 8 2020, In : Molecular Therapy. 28, 1

Research output: Contribution to journalArticle

  • 1 Scopus citations

    CRISPR/Cas9-Mediated Genome Engineering of Primary Human B Cells

    Laoharawee, K., Johnson, M. J. & Moriarity, B. S., Feb 1 2020, In : Methods in molecular biology (Clifton, N.J.). 2115, p. 435-444 10 p.

    Research output: Contribution to journalArticle

  • ORCA/LRWD1 Regulates Homologous Recombination at ALT-Telomeres by Modulating Heterochromatin Organization

    Hsu, R. Y. C., Lin, Y. C., Redon, C., Sun, Q., Singh, D. K., Wang, Y., Aggarwal, V., Mitra, J., Matur, A., Moriarity, B., Ha, T., Aladjem, M. I., Prasanth, K. V. & Prasanth, S. G., May 22 2020, In : iScience. 23, 5, 101038.

    Research output: Contribution to journalArticle

    Open Access
  • PLX3397 treatment inhibits constitutive CSF1R-induced oncogenic ERK signaling, reduces tumor growth, and metastatic burden in osteosarcoma

    Smeester, B. A., Slipek, N. J., Pomeroy, E. J., Laoharawee, K., Osum, S. H., Larsson, A. T., Williams, K. B., Stratton, N., Yamamoto, K., Peterson, J. J., Rathe, S. K., Mills, L. J., Hudson, W. A., Crosby, M. R., Wang, M., Rahrmann, E. P., Moriarity, B. S. & Largaespada, D. A., Jul 2020, In : Bone. 136, 115353.

    Research output: Contribution to journalArticle

  • SEMA4C is a novel target to limit osteosarcoma growth, progression, and metastasis

    Smeester, B. A., Slipek, N. J., Pomeroy, E. J., Bomberger, H. E., Shamsan, G. A., Peterson, J. J., Crosby, M. R., Draper, G. M., Becklin, K. L., Rahrmann, E. P., McCarthy, J. B., Odde, D. J., Wood, D. K., Largaespada, D. A. & Moriarity, B. S., Jan 30 2020, In : Oncogene. 39, 5, p. 1049-1062 14 p.

    Research output: Contribution to journalArticle